Monday Nov 25, 2024
Monday Nov 25, 2024
Friday, 2 December 2016 00:01 - - {{hitsCtrl.values.hits}}
Lanka Hospitals has sought to add to shareholder value by issuing an interim dividend of Rs. 1 per share. This amounts to a payment of 224 million. The dividend was issued taking in to account the positive growth in Lanka Hospitals’ performance in the first nine months of this financial year. As of 30 September, Lanka Hospitals has recorded a Group net profit of Rs. 625 million.
“Lanka Hospitals has always shown great consistency in its performance. We are very happy with the results we have achieved thus far in this year. These results reflect healthy growth trends in almost all of the profit centres under the Lanka Hospitals umbrella. Lanka Hospitals Diagnostics in particular must be noted for its outstanding performance,” enthused Lanka Hospitals Chairman Dr. Sarath Paranavitane.
Lanka Hospitals has achieved many successes in the recent past which have all contributed to its enhanced profitability. Most recently it has achieved MTQUA certification which recognises Lanka Hospitals as one among an elite group of global hospitals. MTQUA certification holds huge weight among medical tourists, as it assures them of treatment, care and services on par with the best in the world.
Lanka Hospitals has also sought to launch new specialised units and has extensively up-graded existing ones. This will ensure specialised, comprehensive treatment needed for varying customer groups suffering from different ailments. For example, the Lanka Hospitals Women’s Wellness Centre caters to the different healthcare issues that women have to deal with in the various stages of their lives.
Further Lanka Hospitals has paved the way for the treatment of blood cancer by providing procedures that were hereto unavailable in Sri Lanka. The Haemato-onclogy and Bone Marrow Transplant Unit headed by Dr. Hewamana, a renowned clinical haematologist and haemato-oncologist with extensive international experience has done much to build this discipline of medicine in Sri Lanka.
Lanka Hospitals Diagnostics (LHD) which is a state- of-the-art laboratory complex manages 10 company owned sample collection centres, as well as several other franchised collection centres in various parts of the island. Lanka Hospitals Diagnostics is the first reference laboratory to be set up in Sri Lanka and is ISO 15189:2007 certified. It has, over the years substantially expanded the breadth of diagnostic tests provided. In fact many tests, which until recently required samples to be sent to countries like India, are carried out by Lanka Hospitals Diagnostics. The company has earned a reputation of excellence, and an increasing number of patients from cities across Sri Lanka have placed their confidence in its facilities.
“Lanka Hospitals offers more than just clinical excellence, and the best expertise and technology. From our steadfast adherence to the highest standards in quality, to our untiring efforts to enhance cost efficiencies, and our relentless commitment to compassionate patient care, Lanka Hospitals consistently raises the benchmarks for healthcare in Sri Lanka. These and more have contributed to our robust financial health and growth year on year,” stated Lanka Hospitals CEO Dr. Prasad Medawatta.
